Mechanism of breast cancer centrosome regulatory protein SEC23B on tumor invasion and metastasis

doi:10.19401/j.cnki.1007-3639.2023.02.008

Abstract

Abstract:

Background and purpose: The novel centrosomal regulatory protein Sec23 homolog B (SEC23B) regulates autophagy in cells, thereby providing energy and nutrients that contribute to tumor growth and distant metastasis. However, whether this role is involved in the mechanism of infiltrative metastasis in breast cancer is unclear. The aim of this study was to investigate the molecular mechanism by which SEC23B promotes breast cancer infiltration and metastasis. Methods: The association between SEC23B expression and breast cancer prognosis and metastasis was analyzed using Kaplan-Meier Plotter database and HCMDB database. MCF-7 cells were divided into vector group (control) and SEC23B overexpression plasmid group (SEC23B), and MDA231-LM2 cells were divided into SEC23B knockdown group (sh-SEC23B) and control group (sh-NC). Western blot was used to detect the expressions of SEC23B, autophagy-associated proteins [dead bone fragment 1 (SQSTM1, p62), microtubule-associated-protein light-chain-3 (LC3)] and extracellular-regulated protein kinases (ERK)/mammalian target of rapamycin (mTOR) pathway proteins in breast cancer cells. Cell migration was assessed by transwell assay and wound healing assay, and autophagic granules in cells were detected by immunofluorescence staining. In addition, an in vivo intraperitoneal tumor model was constructed to study the effect of SEC23B on breast cancer cell metastasis in vivo. Results: The overall survival of breast cancer patients with high SEC23B expression was significantly shorter than that of patients with low SEC23B expression. The expression of SEC23B in metastatic breast cancer was significantly higher than that in breast cancer without metastasis. SEC23B protein levels were lower in primary breast cancer cells (MCF-7, BT-549, MDA-MB-468 and MDA-MB-453) than in metastatic breast cancer cells (MDA231-LM2 and ZR-75-30). Compared with the control group, the SEC23B group significantly accelerated cell migration (P<0.001). Compared with the sh-NC group, the sh-SEC23B group significantly reduced cell migration (P<0.001). Compared with the control group, the expression level of LC3A/B and the formation of autophagy particles in the SEC23B group were significantly increased, while the expression of p62 protein and the phosphorylation levels of mTOR and ERK were decreased. Compared with the sh-NC group, the LC3A/B expression level and the formation of autophagy particles were significantly decreased in the sh-SEC23B group, and the phosphorylation levels of mTOR and ERK were increased, especially under starvation conditions. In in vivo experiments, tumor weight was significantly lower in the sh-SEC23B group compared with the sh-NC group (P<0.01), and there was an increase in necrotic tissue and a decrease in tumor metastasis in lung tissue in mice. sh-SEC23B group mice had a significantly lower number of lung metastatic tumors and LC3 immunohistochemical staining than the sh-NC group (P<0.01). Conclusions: SEC23B induces breast cancer autophagy and promotes cancer cell metastasis by inhibiting ERK/mTOR signaling pathway.

Key words: Sec23 homolog B, Breast cancer, Autophagy, Metastasis, ERK/mTOR signaling pathway

CLC Number:

R737.9

LENG Jie, QIU Guochun, ZHANG Bo, PU Yan. Mechanism of breast cancer centrosome regulatory protein SEC23B on tumor invasion and metastasis[J]. China Oncology, 2023, 33(2): 152-161.

Figures/Tables 5

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

References 20

[1]	王帅, 崔中豪, 杨毅. HER2阳性乳腺癌脑转移的靶向治疗研究进展[J]. 医学研究生学报, 2020, 33(2): 215-219.
	WANG S, CUI Z H, YANG Y. Research progress of targeted therapy for HER2 positive breast cancer with brain metastases[J]. J Med Postgrad, 2020, 33(2): 215-219. doi: 10.1136/pgmj.33.379.215
[2]	FARES J, FARES M Y, KHACHFE H H, et al. Molecular principles of metastasis: a hallmark of cancer revisited[J]. Signal Transduct Target Ther, 2020, 5(1): 28.
[3]	ARAKEL E C, SCHWAPPACH B. Formation of COPI-coated vesicles at a glance[J]. J Cell Sci, 2018, 131(5): jcs209890. doi: 10.1242/jcs.209890
[4]	WEI W, LIU Z G, ZHANG C, et al. A common human missense mutation of vesicle coat protein SEC23B leads to growth restriction and chronic pancreatitis in mice[J]. J Biol Chem, 2022, 298(1): 101536. doi: 10.1016/j.jbc.2021.101536
[5]	ZHOU J G, SINGH P, YIN K H, et al. Non-medullary thyroid cancer susceptibility genes: evidence and disease spectrum[J]. Ann Surg Oncol, 2021, 28(11): 6590-6600. doi: 10.1245/s10434-021-09745-x pmid: 33660127
[6]	RAMALHO-CARVALHO J, MARTINS J B, CEKAITE L, et al. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1[J]. Cancer Lett, 2017, 385: 150-159. doi: 10.1016/j.canlet.2016.10.028
[7]	LIU Z, WANG Q, MAO J W, et al. Comparative proteomic analysis of protein methylation provides insight into the resistance of hepatocellular carcinoma to 5-fluorouracil[J]. J Proteomics, 2020, 219: 103738. doi: 10.1016/j.jprot.2020.103738
[8]	ZEYEN L, DÖRING T, STIELER J T, et al. Hepatitis B subviral envelope particles use the COPII machinery for intracellular transport via selective exploitation of Sec24A and Sec23B[J]. Cell Microbiol, 2020, 22(6): e13181.
[9]	周慧, 韩翰, 周伟强. SAHA-CTSV轴通过诱导过度自噬抑制乳腺癌MCF-7细胞的生长[J]. 中国药理学通报, 2021, 37(4): 504-510.
	ZHOU H, HAN H, ZHOU W Q. SAHA-CTSV induced excessive autophagy and inhibited growth of breast cancer MCF-7 cells[J]. Chin Pharmacol Bull, 2021, 37(4): 504-510.
[10]	MAITI A, HAIT N C. Autophagy-mediated tumor cell survival and progression of breast cancer metastasis to the brain[J]. J Cancer, 2021, 12(4): 954-964. doi: 10.7150/jca.50137 pmid: 33442395
[11]	KING R, LIN Z S, BALBIN-CUESTA G, et al. SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type Ⅱ[J]. Sci Adv, 2021, 7(48): eabj5293. doi: 10.1126/sciadv.abj5293
[12]	YEHIA L, NIAZI F, NI Y, et al. Germline heterozygous variants in SEC23B are associated with cowden syndrome and enriched in apparently sporadic thyroid cancer[J]. Am J Hum Genet, 2015, 97(5): 661-676. doi: 10.1016/j.ajhg.2015.10.001 pmid: 26522472
[13]	YEHIA L, JINDAL S, KOMAR A A, et al. Non-canonical role of cancer-associated mutant SEC23B in the ribosome biogenesis pathway[J]. Hum Mol Genet, 2018, 27(18): 3154-3164. doi: 10.1093/hmg/ddy226
[14]	PIFFOUX M, ERIAU E, CASSIER P A. Autophagy as a therapeutic target in pancreatic cancer[J]. Br J Cancer, 2021, 124(2): 333-344. doi: 10.1038/s41416-020-01039-5
[15]	DOWER C M, WILLS C A, FRISCH S M, et al. Mechanisms and context underlying the role of autophagy in cancer metastasis[J]. Autophagy, 2018, 14(7): 1110-1128. doi: 10.1080/15548627.2018.1450020 pmid: 29863947
[16]	FAN Q, YANG L, ZHANG X D, et al. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells[J]. J Exp Clin Cancer Res, 2018, 37(1): 9. doi: 10.1186/s13046-018-0673-y
[17]	JEONG Y T, SIMONESCHI D, KEEGAN S, et al. The ULK1-FBXW5-SEC23B nexus controls autophagy[J]. Elife, 2018, 7: e42253. doi: 10.7554/eLife.42253
[18]	HUANG S F, TANG M Z, JIANG H L, et al. A COPII subunit interacting with ER-phagy receptor: a new potential avenue to maintaining neuronal homeostasis[J]. Acta Biochim Biophys Sin (Shanghai), 2020, 52(6): 698-700. doi: 10.1093/abbs/gmaa031
[19]	XU H Y, LIU L Y, DING M, et al. Effect of Ganoderma applanatum polysaccharides on MAPK/ERK pathway affecting autophagy in breast cancer MCF-7 cells[J]. Int J Biol Macromol, 2020, 146: 353-362. doi: S0141-8130(19)38698-2 pmid: 31911173
[20]	YANG C Y, CHEN N, LI X, et al. Mutations in the coat complex Ⅱ component SEC23B promote colorectal cancer metastasis[J]. Cell Death Dis, 2020, 11(3): 157. doi: 10.1038/s41419-020-2358-7